Vascular Flashcards
Atherosclerosis
Stage I
Fatty streak
- Endothelium damaged d/t hemodynamic shear stress, oxidize LDL destruction, chronic inflammatory responses, infection, & hypercoagulability → thrombosis
- Lipoproteins enter the arterial intimal layer via endothelium, become entrapped, & promote inflammation
Atherosclerosis
Stage II
Fibrous plaque
- Oxidized lipid accumulation, inflammatory cells, proliferated smooth muscle cells, connective tissue fibers, & Ca2+ deposits
- Blood flow reduction → ischemia to vital organs & extremities → thrombus risk
Atherosclerosis
Stage III
Advanced lesion
- Plaque w/ expanded lipid-rich necrotic core, Ca2+ accumulation, endothelial dysfunction
- Physical disruption to plaque protective cap (ulceration rupture) exposes blood to highly thrombogenic material promoting acute thrombus formation & vasospasm
- Complete occlusion possible → MI, stroke, ischemia
Atherosclerosis Pathophysiology
Generalized, progressive, chronic inflammatory disorder
Fibrous intimal plaques associated w/ endothelial dysfunction develop in the arterial tree
Compromises blood flow to all organs & extremities lead to MI, stroke, & gangreneA
Atherosclerosis Types
- Enlarged plaque reduces blood vessel lumen (ischemia or stable angina) → supply vs. demand & delayed periop MI
- Plaque rupture/ulceration, embolization, & thrombus formation (unstable angina, MI, TIA/CVA) → acute occlusion & early periop MI
- Media atrophy w/ arterial wall weakening (aneurysm dilation)
What’s the most common site for atherosclerotic lesions?
42% aortoiliac peripheral 32% coronary 17% aortic arch branches 6% combined 3% mesenteric renal
What medications to continue prior to vascular surgery?
Aspirin - antiplatelet ↑bleeding ↓GFR Statins - check liver function Diuretics - hypovolemia & electrolyte imbalance Ca2+ channel blockers - HoTN β blockers - bronchospasm ↓HR ↓BP
What medications to discontinue prior to vascular surgery?
ACE inhibitors - HoTN w/ induction & coughing
Plavix (hold 7-8 days) antiplatelet ↑bleeding risk
Hypoglycemic drugs - hypoglycemia & lactic acidosis w/ Metformin
Bare Metal Stent
Do NOT stop antiplatelet therapy < 1mos
↑MI risk
Drug-Eluting Stent
Do NOT stop antiplatelet therapy < 6mos
What’s the critical period for coronary stents to endothelialize?
6 weeks
Recommendations to optimize patient prior to vascular surgery:
Smoking cessation
Weight loss & exercise
Culprit Lesions
Vulnerable plaques w/ high thrombotic complication likelihood
Often located in coronary vessels w/o critical stenosis
Demand Ischemia
Predominant cause periop MI
Supply/demand mismatch
What predicts long-term mortality associated w/ vascular surgery?
Preop renal insufficiency or chronic renal disease → postop failure
LE Peripheral Artery Disease
PAD or atherosclerotic occlusive LE disease
Insufficiency in LEs presenting w/ acute or chronic limb ischemia w/ occlusions distal to the inguinal ligament
LE Peripheral Artery Disease Revascularization Associated Risks
Amputation, stroke, MI, death
Diabetes ↑risk
Assume atherosclerosis present in other areas - cardiac or cerebrovascular
LE Peripheral Artery Disease
Revascularization Preop Considerations
Patients on antiplatelet & anticoagulants
- Ask when last taken
- Consult w/ surgical team about bleeding risk
- ASA, ticagrelor P2Y12 inhibitors, Rivaroxaban Xa inhibitor
- Clopidogrel 30% patients assumed pharmacogenetically resistant
Assess baseline S/S
β blockers & other chronic medications
Peripheral Revascularization Indications
Acute ischemia d/t emboli, thrombus, or pseudoaneurysm postop (femoral line)
Chronic ischemia d/t atherosclerotic plaque progressively narrowing the vessels - claudication w/ eventual vessel thrombosis
Acute Ischemia
Irreversible ischemia damage occurs w/in 4-6hrs
- Urgent thrombolytic therapy and/or angioplasty
- Arteriography
- Surgical intervention
Chronic Ischemia
Surgery indicated when severe disabling claudication & critical limb ischemia (limb salvage)
Peripheral Revascularization
Surgical Approach
Donor artery or vein w/ unobstructed blood flow exposed (common femoral, superficial femoral, or deep femoral) Target distal artery (recipient) exposed at or below the knee (dorsalis pedis or posterior tibial arteries) Tunnel created & graft passed Heparin IV (does not require reversal) Anastomosis constructed & arteriogram to conform adequate blood flow
Peripheral Revascularization
Monitoring
Continuous EKG monitoring w/ ST analysis A-line CVP or PA catheter Foley to monitor I/Os (intravascular volume) Minimal blood loss & 3rd spacing Regional or general approach
Peripheral Revascularization
Emergency Surgery Considerations
Monitor K+ levels Myoglobinemia Fasciotomy? Coagulation status EKG ischemia
Peripheral Revascularization
Regional vs. General
Assess coagulopathy or anticoagulation therapy
Spinal best to avoid hematoma
No difference b/w regional & general based on cardiopulmonary complications
Regional 5x superior to general r/t graft occlusion complication rates
Graft Occlusion
Significant w/ general anesthesia approach in postop period
Hypercoagulable state
↓fibrinolysis → fibrinogen not broken down & clots form
↑Epi/NE/cortisol
Graft patency maintained w/ regional 2° ↑blood flow w/ sympathectomy
Peripheral Revascularization
Anesthetic Management Intraop
AVOID vasopressors
Keep feet warm
Regional:
- L1 → L4 dermatomes
- T10 level adequate
- Epidural dosing 9-12mL including test dose (elderly patients require ↓dosing)
General:
- Balanced anesthetic w/ opioids, inhalational agent, N2O, & neuromuscular blocker
- Minimal opioids to facilitate extubation
- Deepen anesthetic during tunneling phase (3-5mcg/kg Fentanyl)
- Avoid hemodynamic extremes (β blockers often necessary)
Peripheral Revascularization
Anesthetic Management Postop
Stress reduction & pain control ↑MI risk postop Continuous EKG monitoring w/ ST analysis Control HR & BP Avoid anemia Hgb < 9g/dL Frequent peripheral pulse checks
LE Endovascular
Less invasive procedure to deploy stent & improve artery patency
General, neuraxial, or MAC
Percutaneous procedures (often MAC sedation)
Open access (femoral stenosis) consider GA
Carotid Artery Disease
1° carotid artery disease cause = atherosclerosis
Commonly occurs at the common carotid artery & internal/external carotid arteries
Carotid Artery Disease S/S
Fatal or debilitating stroke
TIA
Amaurosis fugax (transient monocular blindness attack)
Asymptomatic bruit
___ % strokes are ___
Approximately 87% strokes are ischemic (cerebral thrombosis or embolism)
< 20% strokes are preceded TIA
What disease accounts for up to 20% all strokes?
Extracranial atherosclerotic
Carotid Endarterectomy
Indications
↓symptoms & prevent stroke
Most common peripheral vascular surgery
Symptomatic patients w/ 70-99% carotid stenosis
How to manage asymptomatic < 70% carotid stenosis?
Medical therapies (ASA) Percutaneous angioplasty/stenting
Carotid Endarterectomy
Preop Assessment
Ask about recent symptoms? MI or TIA
Optimize medical management
- β blocker, statins, antiplatelet therapy
- HTN control, restore intravascular volume, reset cerebral autoregulation
- Diabetes control
Coronary artery disease common (1st treat carotids d/t CABG bypass & impaired cerebral perfusion w/ carotid plaques)
- Assess coronary angiograms
SIGNIFICANT Coronary Artery Disease S/S
Unstable angina
Decompensated heart failure
Significant valve disease
Carotid Endarterectomy
Anesthetic Management
Awake vs. GETA Continue ASA & cardiac medications Type & screen EKG to monitor leads II & V - rhythm disturbances & ST segment changes Cerebral oximeter A-line ACTs intraop Central line rare PIV x2 Fluid warmer Lower body warmer Arms tucked
Anterior Leads
V3 & V4
Inferior Leads
II, III, & AVF
Lateral Leads
I, AVL, V5, & V6
Septal Leads
V1 & V2
Carotid Endarterectomy
Medications & Infusions
Phenylephrine 20-300mcg/min OR 0.15-0.75mcg/kg/min
Remifentanil 0.05-0.2mcg/kg/min
Clevidipine 1mg or 1-2mg/hr double every 90sec up to 32mg/hr
Nitroglycerin
β blockers (Labetalol 5mg, Esmolol 10mg or 100-300mcg/kg/min, Metoprolol 1mg)
Ephedrine 5-10mg
Heparin & Protamine
Carotid Endarterectomy
MAP Goals
High-normal range especially during carotid clamping to increase collateral flow & prevent cerebral ischemia
Potential to induce HTN 10-20% above baseline during carotid clamping
Careful to prevent ↑MVO2
What response will be anticipated in response to carotid sinus manipulation? Why?
Bradycardia & HoTN d/t the baroreceptor reflex
How to treat sudden bradycardia & HoTN?
Stop surgical manipulation
Ask surgeon to infiltrate the carotid bifurcation w/ 1% Lidocaine to prevent further episodes
Where are baroreceptors located?
Carotid sinuses & aortic arch
Carotid Endarterectomy
Emergence
Assess neuro status - deficits require immediate attention (angiography, reoperation, or both)
HTN & tachycardia associated w/ emergence & extubation
- Consider β blocker or sedation to smooth emergence
↑pressure stresses the new suture lines
Awake Carotid Endarterectomy
Best way to monitor function
Patient has ball to squeeze Q5min checks
Minimal or NO sedation (Midazolam 0.5mg + Fentanyl 25mcg) to prevent interference w/ neurological assessment
Avoid Propofol
Consider Esmolol during induction/direct laryngoscopy to prevent sympathetic response
Patients potentially get hot & restless under the drapes
Uncover their legs
Prevent/treat HTN or HoTN